Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 9381–9400 of 17,529 recalls

February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Medroxyprogesterone Acetate USP (Micronized) for prescription compounding 1000 g

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Pentoxifylline USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Flurbiprofen USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Vancomycin HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Naltrexone HCl USP (Dihydrate) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Vardenafil HCl USP (trihydrate) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Sumatriptan USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levofloxacin Hemihydrate USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Clindamycin Phosphate USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone (Soy) (Micronized) USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone Enanthate USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Estrone USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Lincomycin HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Hydroxyprogesterone Caproate USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Lidocaine USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Ursodiol USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Cyclosporine USP

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Celecoxib USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Lidocaine HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone USP (Micronized) (Yam) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund